Related Experiment Video
Updated: Nov 9, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19
Qiang Tang1, Yanwei Liu1, Yingfeng Fu1
1Department of General Surgery, Shiyan Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Insights
COVID-19 disease aggravation is linked to comorbidities like hypertension and diabetes, along with symptoms such as dyspnea and lymphocytopenia. Advanced age and specific biomarkers predict severe outcomes in patients with 2019 Coronavirus Disease.
Area of Science:
- Infectious Diseases
- Internal Medicine
- Clinical Research
Background:
- The 2019 Coronavirus Disease (COVID-19) pandemic poses a significant global health challenge.
- Understanding factors predicting disease severity is crucial for patient management and resource allocation.
Purpose of the Study:
- To retrospectively analyze clinical data of COVID-19 patients.
- To identify predictors of disease aggravation and assess patient prognosis.
Main Methods:
- Retrospective analysis of clinical data from 197 COVID-19 patients.
- Comparison of characteristics between patients with and without disease aggravation.
- Multivariable regression analysis to identify significant predictors.
- Kaplan-Meier analysis for prognosis evaluation.
Main Results:
- 88 out of 197 patients experienced disease aggravation.
- Aggravation cases showed higher rates of comorbidities (hypertension, diabetes) and symptoms (dyspnea).
- Patients with aggravation had increased incidence of organ damage (liver, kidney, heart).
- Advanced age, comorbidities, dyspnea, lymphopenia, and elevated Fbg, CTnI, IL-6, and serum ferritin predicted aggravation.
- 64.9% of patients survived without ICU transfer.
Conclusions:
- Comorbidities, specific clinical symptoms, and laboratory markers are associated with COVID-19 disease progression.
- Identifying these predictors can aid in early risk stratification and management of severe COVID-19 cases.
- Prognosis for a majority of patients was favorable, with a significant portion avoiding ICU admission.
Abstract:
The 2019 Coronavirus Disease (COVID-19) has become an unprecedented public crisis. We retrospectively investigated the clinical data of 197 COVID-19 patients and identified 88 patients as disease aggravation cases. Compared with patients without disease aggravation, the aggravation cases had more comorbidities, including hypertension (25.9%) and diabetes (20.8%), and presented with dyspnoea (23.4%), neutrophilia (31.5%), and lymphocytopenia (46.7%). These patients were more prone to develop organ damage in liver, kidney, and heart (P < 0.05). A multivariable regression analysis showed that advanced age, comorbidities, dyspnea, lymphopenia, and elevated levels of Fbg, CTnI, IL-6, and serum ferritin were significant predictors of disease aggravation. Further, we performed a Kaplan-Meier analysis to evaluate the prognosis of COVID-19 patients, which suggested that 64.9% of the patients had not experienced ICU transfers and survival from the hospital.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Myocarditis III: Medical Management
Coronary Artery Disease I: Introduction
Pneumonia III: Complications and Assessment

